MONOPOLAR HOT-BIOPSY FORCEPS, SINGLE USE
Informazioni principali
- Nome commerciale:
- MONOPOLAR HOT-BIOPSY FORCEPS, SINGLE USE
- Commercializzato da:
- ENDO-THERAPEUTICS,INC.
- Codice ATC:
- G0308010102
- Utilizzare per:
- Esseri umani
- Tipo di medicina:
- Dispositivo medico
Documenti
- per il pubblico:
- Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.
Richiedi il foglio illustrativo per il pubblico.
- per i professionisti:
- Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.
Richiedi il foglio illustrativo per i professionisti.
Localizzazione
- Disponibile in:
-
Italia
- Lingua:
- italiano
Informazioni terapeutiche
- Gruppo terapeutico:
- PINZE DA BIOPSIA ENDOSCOPICA GASTRO-INTESTINALE A CALDO
Altre informazioni
Status
- Fonte:
- Ministero della Salute - Italia
- Stato dell'autorizzazione:
- N
- Data dell'autorizzazione:
- 17-11-2009
- Ultimo aggiornamento:
- 09-08-2016
- Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.
Richiedi il foglio illustrativo per il pubblico.
- L'accesso a questo documento è disponibile solo per gli utenti registrati.
Registrati ora per abilitare l'accesso completo
6-12-2018
Formula Brands Inc. recalls Betty Crocker Single Serve Pod Coffee Maker
The affected product can overheat during use, posing a burn hazard.
Health Canada
20-10-2018
Scientific Opinion of Flavouring Group Evaluation 411 (FGE.411): 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide from chemical group 30 (miscellaneous substances)
Published on: Fri, 19 Oct 2018 00:00:00 +0200 EFSA was requested to deliver a scientific opinion on the implications for human health of the flavouring substance 2‐(4‐methylphenoxy)‐N‐(1H‐pyrazol‐3‐yl)‐N‐(thiophen‐2‐ylmethyl)acetamide [FL‐no: 16.133], in the Flavouring Group Evaluation 411 (FGE.411), according to Regulation (EC) No 1331/2008 of the European Parliament and of the Council. The substance has not been reported to occur in natural source materials of botanical or animal origin. It is intende...
Europe - EFSA - European Food Safety Authority Publications
26-9-2018
Medical Devices Safety Update, Volume 6, Number 5, September 2018
Case studies in Incident Report Investigations; review of reusable biopsy forceps devices; care required with patient lifters
Therapeutic Goods Administration - Australia
4-6-2018
Hospira Issues a Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection, USP, in the Carpuject™ Syringe System due to the Potential Presence of Particulate Matter
Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe system (NDC 0409-1782-69), to the hospital/institution level due to the potential presence of embedded and loose particulate matter on the syringe plunger.
FDA - U.S. Food and Drug Administration
4-6-2018
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter
The patient has a low likelihood of experiencing adverse events ranging from local irritation, allergic reactions, phlebitis, end-organ granuloma, tissue ischemia, pulmonary emboli, pulmonary dysfunction, pulmonary infarction, and toxicity.
FDA - U.S. Food and Drug Administration
22-2-2012
Changed criteria for single reimbursement for osteoporosis medicines other than alendronate
As of 5 March 2012, it will only be possible to obtain a single reimbursement grant for the other medicines used in osteoporosis treatment for patients that cannot use alendronate. The criteria for single reimbursement are changed because of the large price gaps between the different medicines, where the reimbursement price of alendronate is by far the lowest.
Danish Medicines Agency
26-9-2018
The single-use internal condom (formerly the single-use female condom) is the only female-controlled barrier method intended to provide protection against pregnancy & STI transmission. Check out the FDA's birth control guide: https://go.usa.gov/xPDQw #M
The single-use internal condom (formerly the single-use female condom) is the only female-controlled barrier method intended to provide protection against pregnancy & STI transmission. Check out the FDA's birth control guide: https://go.usa.gov/xPDQw #MedicalDevices
FDA - U.S. Food and Drug Administration
25-9-2018
Single use devices should not be reused. Your health care provider or emergency personnel may be able to assist you in obtaining a supply of single use devices during an emergency. Click the link to find out how to safely reuse multiple use devices: http
Single use devices should not be reused. Your health care provider or emergency personnel may be able to assist you in obtaining a supply of single use devices during an emergency. Click the link to find out how to safely reuse multiple use devices: https://go.usa.gov/xPjCj pic.twitter.com/yVSNlc5Qb0
FDA - U.S. Food and Drug Administration
4-5-2018
Medical devices and IVDs: Cancellations from the ARTG
Cancellation of Profile Surgical Forceps, biopsy
Therapeutic Goods Administration - Australia